Myomo (MYO) Non-Current Deffered Revenue (2017 - 2023)
Myomo's (MYO) quarterly Non-Current Deffered Revenue came in at $126.0 in Q2 2023, down 86.51% YoY from $934.0 in Q2 2022, and down 59.62% on a QoQ basis from $312.0 in Q1 2023.
Myomo (MYO) Non-Current Deffered Revenue (2017 - 2023) Analysis & Trends
Myomo (MYO) has 7 years of Non-Current Deffered Revenue data on file, last reported at $126.0 in Q2 2023.
- Quarterly Non-Current Deffered Revenue fell 86.51% year-over-year to $126.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $126.0 (down 86.51% YoY) and the FY2022 annual result came in at $498.0, down 60.03% from the prior year.
- Non-Current Deffered Revenue slipped to $126.0 in Q2 2023, from $312.0 in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $8700.0 in Q2 2020 to a low of $126.0 in Q2 2023.
- A 5-year average of $1614.1 and a median of $1495.0 in 2019 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2020 — Non-Current Deffered Revenue changed 0.0% — and 2023, when it tumbled 86.51%.
- Tracing MYO's Non-Current Deffered Revenue over 5 years: stood at $1495.0 in 2019, then changed by 0.0% to $1495.0 in 2020, then dropped by 16.66% to $1246.0 in 2021, then sank by 60.03% to $498.0 in 2022, then slumped by 74.7% to $126.0 in 2023.
- The last three Non-Current Deffered Revenue figures came in at $126.0 (Q2 2023), $312.0 (Q1 2023), and $498.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 539.34 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | - |
| 10 | Myomo | 67.26 Mn | 48.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 126.00 |
| Mar 31, 2023 | 312.00 |
| Dec 31, 2022 | 498.00 |
| Sep 30, 2022 | 685.00 |
| Jun 30, 2022 | 934.00 |
| Mar 31, 2022 | 1,246.00 |
| Dec 31, 2021 | 1,246.00 |
| Sep 30, 2021 | 1,495.00 |
| Jun 30, 2021 | 1,495.00 |
| Mar 31, 2021 | 1,495.00 |
| Dec 31, 2020 | 1,495.00 |
| Sep 30, 2020 | 1,495.00 |
| Jun 30, 2020 | 8,700.00 |
| Mar 31, 2020 | 1,495.00 |
| Dec 31, 2019 | 1,495.00 |
| Sep 30, 2018 | 249.00 |
| Jun 30, 2018 | 45,496.00 |
| Mar 31, 2018 | 45,496.00 |
| Dec 31, 2017 | 44,042.00 |